Aditya Birla Sun Life Pharma & Healthcare Fund - IDCW - Regular Plan

Other Plans and Options
  • 0.18 %Nav, as on 01-12-2023

  • Previous Nav

  • Net Change on 01-12-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 11.46 9.98 28.18 14.69 17.07 14.62

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 29.68 16.23 19.42 1.88 5,539.19
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 31.26 16.11 20.89 2.00 3,270.55
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 28.14 16.30 19.16 2.10 1,982.47
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 24.30 15.20 21.25 2.05 1,783.19
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 26.18 15.79 23.31 2.06 1,717.54

Fund Holdings as on 31-October-2023

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Torrent Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Fortis Healthcare Limited

  • Sanofi India Limited

  • Lupin Limited

  • Zydus Lifesciences Limited

  • J.B. Chemicals & Pharmaceuticals Limited

  • Dr. Reddys Laboratories Limited

  • Jupiter Life Line Hospitals Ltd

  • Gland Pharma Limited

  • Alkem Laboratories Limited

  • Clearing Corporation of India Limited

  • Ajanta Pharmaceuticals Limited

  • Eris Lifesciences Limited

  • Abbott India Limited

  • ALEMBIC PHARMACEUTICALS LIMITED

  • Strides Pharma Science Limited

  • Vijaya Diagnostic Centre Limited

  • Star Health & Allied Insurance Limited

  • Mankind Pharma Ltd

  • Global Health Ltd/India

  • Biocon Limited

  • Vinati Organics Limited

  • Granules India Limited

  • Medplus Health Services Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

  • Chemicals

View More

Most Recent Dividend

  • 22/09/2023

  • 27/09/2022

  • 28/09/2021

  • 01/10/2020

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹506 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.03(0.18%)yesterday to ₹17.17.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111